Skip to main content

Table 1 Patient characteristics

From: Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine

Characteristics No. of patients (%)
Age
 Median 72
 Range 48–88
Sex
 Male 133 (92.4)
 Female 11 (7.6)
Former or current smokers
 Yes 141 (97.9)
 No 3 (2.1)
Pathological stage
 IA 48 (33.3)
 IB 40 (27.8)
 IIA 21 (14.6)
 IIB 11 (7.6)
 IIIA 23 (16.0)
 IIIB 1 (0.70)
Recurrence
 Yes 62 (43.1)
 No 82 (56.9)
Lymphatic permeation
 Yes 72 (50.0)
 No 72 (50.0)
Venous Invasion
 Yes 72 (50.0)
 No 72 (50.0)
Post-operative adjuvant therapy
 Yes 39 (27.1)
 UFT based 17 (51.5)
 TS-1 based 8 (24.2)
 CBDCA based 5 (15.1)
 CDDP based 3 (9.1)
 No 105 (72.9)